Skip to main content
CriticalFDAfda-F-1119-2019SALMONELLA CONTAMINATION

Focaccia Vegetable Pesto Sandwich packaged in plastic nonflexible containers

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (Salmonella contamination). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
29
Recall Date
January 24, 2019
Issuing Agency
Hazard
Salmonella Contamination

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1119-2019.

Product potentially contaminated with Salmonella.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1119-2019.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Whole Foods Market or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1119-2019.

Whole Foods Market

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Whole Foods Market Recall FAQ

Whole Foods Market is the subject of a produce safety report: Focaccia Vegetable Pesto Sandwich packaged in plastic nonflexible containers. The notice was published on January 24, 2019 by the U.S. Food and Drug Administration (FDA). Approximately 29 units are potentially affected.